Global Antihypertensive Drugs Market Growth is augmented by Surging Prevalence of Hypertension across the Globe
Inkwood
Research estimates that the Global Antihypertensive Drugs Market is
projected to evolve at a CAGR of 3.21% in terms of revenue during the
forecasting years of 2019-2028.
“Browse 33
Market Data Tables and 41 Figures spread over 160 Pages, along with an in-depth
TOC on the Global
Antihypertensive Drugs Market Forecast 2019-2028.”
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/antihypertensive-drugs-market/#request-free-sample
Antihypertensive
drugs are used to treat high blood pressure or hypertension, a chronic
condition related to the rise in pressure of blood in the patient’s arteries.
The ailment is often accompanied by other severe and fatal conditions like an
aneurysm, heart failure, dementia, and heart attack. Thus, the treatment of
this medical condition necessitates early diagnosis and management using
antihypertensive drugs like vasodilators, calcium channel blockers, and
beta-blockers.
Prevalence
of Hypertension Around the World Boosts Market Growth
A
worldwide increase in the incidence of hypertension has become a significant
cause of cardiovascular diseases. According to the Centers for Disease Control
and Prevention, 75 million adults in the United States suffered from
hypertension in 2017. In Europe, over 1 in 4 adults had high blood pressure,
which accounted for over 12 million people in 2015. Moreover, the condition is
predicted to affect more than 1.5 billion people globally, by 2015. Thus, the
alarming rise in the prevalence of hypertension around the world is leading to
a global surge in demand for antihypertensive drugs.
According
to the American College of Cardiology, there is no clinical indication that
establishes the advantages or hazards of taking antihypertensive drugs in
patients with COVID-19. Health authorities suppose that patients suffering from
hypertension are at a higher risk as they may have other underlying ailments
like diabetes and cardiovascular diseases. Additionally, completely stopping
the medication is unsafe and may lead to a stroke or heart failure. Thus, there
is no curb or increase in the consumption of antihypertensive drugs across the
market, given the pandemic.
To know more
about this report, request
a free sample copy.
E-commerce
Websites & Online Drug Stores is the Fastest Growing End-User
The
e-commerce segment in the end-user category is projected to register the
highest CAGR during the forecast period. Online pharmacies are also termed as
internet pharmacies, e-commerce pharmacies or mail-order pharmacies that
function and operate over the internet. Preference for online purchase of drugs
over traditional buying, increase in awareness of online pharmacies, and a rise
in internet users have contributed to the global antihypertensive drugs market
growth. Internet pharmacies offer more benefits like convenience, reliable and
easy access to patient reviews, price comparisons, and lesser expenses, which
further drive the market growth. However, unethical and fraudulent suppliers
often provide outdated and substituted medicines, which is anticipated to
obstruct market growth.
North
America is projected to dominate the Global Market by 2028
North
America dominated the global antihypertensive market in 2019, harboring the
largest revenue share, and is expected to continue the trend throughout the forecast
period. The key factors driving the antihypertensive drugs market growth in
this region are the rise in the prevalence of hypertension and chronic kidney
disorders. Moreover, the presence of eminent players like Johnson & Johnson
and Merck & Co Inc propels the market growth in this region.
There
exists an extensive rivalry between primary companies in the market. For
instance, in the current competition between Bayer & GlaxoSmithKline, Eli
Lilly & ICOS, and Pfizer, the extent is highly competitive in the erectile
dysfunction space. Major companies, harboring their status in the market are
Johnson & Johnson, Lupin Limited, Bio-Rad Laboratories Inc, AstraZeneca
Plc, Medtronic Plc, etc.
About
Inkwood Research
Inkwood Research specializes in
syndicated & customized research reports and consulting services. Market
intelligence studies with relevant fact-based research are customized across
industry verticals such as technology, automotive, chemicals, materials,
healthcare, and energy, with an objective comprehension that acknowledges the
business environments. Our geographical analysis comprises of North & South
America, CEE, CIS, Middle East, Europe, Asia, and Africa.
Contact Us
+1 857-302-4704
Related Reports:
Comments
Post a Comment